The Role of Cholinesterase Inhibitors in Alzheimer’s Disease
作者： Peter P. Lamy
DOI: 10.2165/00023210-199401020-00006
关键词:
摘要: Alzheimer’s disease is the most prevalent late-onset neurodegenerative disorder of unknown origin.
springer.com
sci-hub.se 参考文章(175)
Jones Cr, Davis M, Letter: Replacement drug for edrophonium bromide. The Medical Journal of Australia. ,vol. 2, pp. 650- ,(1975)
Kramer-Ginsberg E, Lobel D, Davis Kl, Aryan M, Davidson M, Silverman J, Mohs Rc, Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. Psychopharmacology Bulletin. ,vol. 24, pp. 458- 462 ,(1988)
Deptula D, Pomara N, Singh R, Pretreatment postural blood pressure drop as a possible predictor of response to the cholinesterase inhibitor velnacrine (HP 029) in Alzheimer's disease. Psychopharmacology Bulletin. ,vol. 27, pp. 301- ,(1991)
B Reisberg, S H Ferris, Brief Cognitive Rating Scale (BCRS). Psychopharmacology Bulletin. ,vol. 24, pp. 629- 636 ,(1988)
Kumar, Calache M, Treatment of Alzheimer's disease with cholinergic drugs. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 29, pp. 23- 37 ,(1991)
A new scale for the assessment of depressed mood in demented patients. American Journal of Psychiatry. ,vol. 145, pp. 955- ,(1988) , 10.1176/AJP.145.8.955
KEITH A Wesnes, Pauline M Simpson, LINDA White, Sally Pinker, GABRIELA Jertz, MICHAEL Murphy, KLAUDIUS Siegfried, None, Cholinesterase inhibition in the scopolamine model of dementia. Annals of the New York Academy of Sciences. ,vol. 640, pp. 268- 271 ,(1991) , 10.1111/J.1749-6632.1991.TB00231.X
B Reisberg, T Crook, M J de Leon, S H Ferris, Global Deterioration Scale (GDS). Psychopharmacology Bulletin. ,vol. 24, pp. 661- 663 ,(1988)
E.G. Rowan, Alan L. Harvey, Effects of tacrine, aminopyridines, and physostigmine on acetylcholinesterase, acetylcholine release, and potassium currents. Advances in Neurology. ,vol. 51, pp. 227- 233 ,(1990)
H. Erzigkeit, The SKT — A Short Cognitive Performance Test as an Instrument for the Assessment of Clinical Efficacy of Cognition Enhancers Diagnosis and Treatment of Senile Dementia. pp. 164- 174 ,(1989) , 10.1007/978-3-642-46658-8_14